Brain zaps to beat opioid cravings? new trial tests personalized deep brain stimulation

NCT ID NCT07214467

First seen Nov 01, 2025 · Last updated Apr 28, 2026 · Updated 24 times

Summary

This early study tests whether a personalized deep brain stimulation (DBS) device can safely reduce cravings and opioid use in people with severe, treatment-resistant opioid addiction. Six adults aged 22-75 who have used opioids for over 5 years will first undergo brain mapping to identify craving-related signals, then receive adaptive stimulation. The goal is to see if this approach is safe and can help control the disease long-term.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for SUBSTANCE USE DISORDER (SUD) are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • University of California, San Francisco

    RECRUITING

    San Francisco, California, 94143, United States

    Contact

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

    Contact

    Contact

    Contact

    Contact Phone: •••-•••-•••• Email: •••••@•••••

Conditions

Explore the condition pages connected to this study.